H. Friedman

1.7k total citations
53 papers, 1.3k citations indexed

About

H. Friedman is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, H. Friedman has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 16 papers in Pharmacology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in H. Friedman's work include Epilepsy research and treatment (17 papers), Neuroscience and Neuropharmacology Research (10 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). H. Friedman is often cited by papers focused on Epilepsy research and treatment (17 papers), Neuroscience and Neuropharmacology Research (10 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). H. Friedman collaborates with scholars based in United States, Germany and Canada. H. Friedman's co-authors include Richard I. Shader, David J. Greenblatt, Susan Willavize, Jerold S. Harmatz, Rongyue Teng, Joseph M. Scavone, John Vincent, Hermann R. Ochs, Ethan S. Burstein and John Vincent and has published in prestigious journals such as JAMA, Gastroenterology and Radiology.

In The Last Decade

H. Friedman

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Friedman United States 24 341 228 227 204 184 53 1.3k
G. Bianchetti France 21 277 0.8× 125 0.5× 184 0.8× 255 1.3× 144 0.8× 78 1.5k
Thomas K. Henthorn United States 28 423 1.2× 143 0.6× 207 0.9× 169 0.8× 140 0.8× 86 2.0k
Steven Troy United States 19 494 1.4× 164 0.7× 137 0.6× 218 1.1× 116 0.6× 49 1.3k
Arthur B. Straughn United States 26 378 1.1× 217 1.0× 271 1.2× 460 2.3× 111 0.6× 71 2.1k
Kari Aranko Finland 20 156 0.5× 165 0.7× 328 1.4× 209 1.0× 208 1.1× 47 1.6k
S. A. Kaplan United States 20 465 1.4× 236 1.0× 270 1.2× 234 1.1× 115 0.6× 42 1.7k
David J. Greenblatt United States 22 304 0.9× 196 0.9× 592 2.6× 231 1.1× 166 0.9× 35 1.5k
Stanley W. Carson United States 21 181 0.5× 98 0.4× 223 1.0× 159 0.8× 143 0.8× 54 1.3k
Marcia D. Allen United States 16 232 0.7× 204 0.9× 207 0.9× 439 2.2× 205 1.1× 30 1.4k
J S Harmatz United States 16 192 0.6× 123 0.5× 336 1.5× 228 1.1× 98 0.5× 22 1.0k

Countries citing papers authored by H. Friedman

Since Specialization
Citations

This map shows the geographic impact of H. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Friedman more than expected).

Fields of papers citing papers by H. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Friedman. The network helps show where H. Friedman may publish in the future.

Co-authorship network of co-authors of H. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of H. Friedman. A scholar is included among the top collaborators of H. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Friedman. H. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, John, et al.. (2000). Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. British Journal of Clinical Pharmacology. 50(5). 455–463. 45 indexed citations
2.
Vincent, John, et al.. (1998). The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects. The American Journal of Surgery. 176(6). 23S–26S. 12 indexed citations
3.
Vincent, John, et al.. (1998). The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects. The American Journal of Surgery. 176(6). 32S–38S. 14 indexed citations
4.
Vincent, John, Renli Teng, Deepak Dalvie, & H. Friedman. (1998). Pharmacokinetics and metabolism of single oral doses of trovafloxacin. The American Journal of Surgery. 176(6). 8S–13S. 23 indexed citations
5.
Teng, Rongyue, et al.. (1997). Oral bioavailability of trovafloxacin with and without food in healthy volunteers. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 87–92. 43 indexed citations
6.
Schmider, Jürgen, et al.. (1997). Biotransformation of Mestranol to Ethinyl Estradiol In Vitro: The Role of Cytochrome P‐450 2C9 and Metabolic Inhibitors. The Journal of Clinical Pharmacology. 37(3). 193–200. 34 indexed citations
7.
Vincent, John, et al.. (1997). Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 81–86. 31 indexed citations
8.
Vincent, John, Jürgen Venitz, Rongyue Teng, et al.. (1997). Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 75–80. 59 indexed citations
9.
Teng, Rongyue, et al.. (1997). Effect of Maalox and omeprazole on the bioavailability of trovafloxacin. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 93–97. 26 indexed citations
10.
Foulds, George, David R. Luke, Rongyue Teng, et al.. (1996). The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. Journal of Antimicrobial Chemotherapy. 37(suppl C). 37–44. 43 indexed citations
11.
Friedman, H., David J. Greenblatt, Gary Peters, et al.. (1992). Pharmacokinetics and pharmacodynamics of oral diazepam: Effect of dose, plasma concentration, and time. Clinical Pharmacology & Therapeutics. 52(2). 139–150. 75 indexed citations
12.
Fleishaker, Joseph C., et al.. (1992). Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in healthy volunteers. European Journal of Clinical Pharmacology. 42(3). 287–94. 8 indexed citations
13.
Friedman, H., D. Eugene Redmond, & David J. Greenblatt. (1991). Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys. Psychopharmacology. 104(1). 103–105. 19 indexed citations
14.
Fleishaker, Joseph C., Thomas C. Smith, H. Friedman, & J. Paul Phillips. (1991). N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10–50 mg oral doses in healthy volunteers. Psychopharmacology. 105(2). 181–185. 8 indexed citations
15.
Greenblatt, David J., Jerold S. Harmatz, H. Friedman, Ann Locniskar, & Richard I. Shader. (1989). A Large-Sample Study of Diazepam Pharmacokinetics. Therapeutic Drug Monitoring. 11(6). 652–657. 37 indexed citations
16.
Friedman, H., et al.. (1989). The Effects of Flurbiprofen, Aspirin, Cimetidine, and Antacids on the Gastric and Duodenal Mucosa of Normal Volunteers. An Endoscopic and Photographic Study. The Journal of Clinical Pharmacology. 29(6). 559–562. 4 indexed citations
17.
Burstein, Ethan S., et al.. (1988). Quantitation of Flurazepam and Three Metabolites by Electron Capture Gas Liquid Chromatography. Journal of Analytical Toxicology. 12(3). 122–125. 10 indexed citations
18.
Friedman, H., et al.. (1988). Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites. Psychopharmacology. 94(3). 386–91. 31 indexed citations
19.
Burstein, Ethan S., H. Friedman, & David J. Greenblatt. (1987). Simplified measurement of haloperidol by gas chromatography with nitrogen-phosphorus detection. Journal of Chromatography B Biomedical Sciences and Applications. 423. 380–382. 4 indexed citations
20.
Friedman, H.. (1986). Underivatized measurement of bromazepam by gas chromatography-electron capture detection to single-dose pharmacokinetics. Journal of Chromatography A. 378. 473–477. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Bianchetti Breakdown of academic impact, for papers by Thomas K. Henthorn Breakdown of academic impact, for papers by Steven Troy Breakdown of academic impact, for papers by Arthur B. Straughn Breakdown of academic impact, for papers by Kari Aranko Breakdown of academic impact, for papers by S. A. Kaplan Breakdown of academic impact, for papers by David J. Greenblatt Breakdown of academic impact, for papers by Stanley W. Carson Breakdown of academic impact, for papers by Marcia D. Allen Breakdown of academic impact, for papers by J S Harmatz
Rankless by CCL
2026